scholarly article | Q13442814 |
P356 | DOI | 10.5414/CNP60090 |
P698 | PubMed publication ID | 12940610 |
P2093 | author name string | K Miyagawa | |
T Inoue | |||
T Nakanishi | |||
M Izumi | |||
N Shibahara | |||
Y Takamitsu | |||
R Itahana | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | type 2 diabetes | Q3025883 |
pharmacokinetics | Q323936 | ||
P304 | page(s) | 90-95 | |
P577 | publication date | 2003-08-01 | |
P1433 | published in | Clinical Nephrology | Q15763520 |
P1476 | title | Pharmacokinetics of nateglinide and its metabolites in subjects with type 2 diabetes mellitus and renal failure | |
P478 | volume | 60 |
Q36101262 | Anti-Hyperglycemic Agents and New-Onset Acute Myocardial Infarction in Diabetic Patients with End-Stage Renal Disease Undergoing Dialysis |
Q26768488 | Diabetes mellitus and renal failure: Prevention and management |
Q59220162 | Diabetic nephropathy |
Q26799515 | Hypoglycemia in Patients with Diabetes and Renal Disease |
Q26766259 | Management of diabetes mellitus in individuals with chronic kidney disease: therapeutic perspectives and glycemic control |
Q33792375 | Management of diabetes mellitus in patients with chronic kidney disease |
Q42157131 | Management of hyperglycemia in patients with diabetes mellitus and chronic renal failure |
Q38063169 | Management of post-transplant diabetes |
Q47145533 | Meglitinides increase the risk of hypoglycemia in diabetic patients with advanced chronic kidney disease: a nationwide, population-based study |
Q38193694 | Metformin and other antidiabetic agents in renal failure patients |
Q92431835 | POTENTIAL ADVANTAGE OF REPAGLINIDE MONOTHERAPY IN GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND SEVERE RENAL IMPAIRMENT |
Q28073342 | Update on the treatment of type 2 diabetes mellitus |
Search more.